In other words, 90% of initial demand from all new patient attempts go unrealized, signifying significant patient leakage
May your reconstitutions stay precise, your titrations stay smooth, and your protocols stay effective.
Collaborative efforts among researchers, clinicians, and pharmaceutical developers are essential to translate these scientific insights into effective and accessible treatments
Retrieved March 10, 2026, from The four states that removed coverage of GLP-1 AOMs for weight loss collectively spent approximately $2.5 billion on Wegovy, Zepbound, and Saxenda in a 30-month span, on a gross basis for all indications
Real Results: Our Clinics Experience At Rheumatologist OnCall, we have implemented a program designed to serve patients with obesity and autoimmune diseases, including arthritis
The starting dose is 5 mg, escalating to 10 mg after four weeks